Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2023-08-30 Board/Management Inform…
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Changes to CEO Remuneration and Employment Contract 3 pages 231.1KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 31 August 2023 regarding changes to the CEO's remuneration package at Medical Developments International Ltd. It details amendments to the CEO's short term and long term incentive plans, conditions subject to shareholder approval at the upcoming Annual General Meeting (AGM), and other employment contract terms. The document does not contain financial statements or comprehensive financial performance data but focuses on management compensation changes. It is not a full annual or interim report, nor an earnings release or investor presentation. It is also not a proxy solicitation or voting results announcement. The content fits best under Board/Management Information (MANG) as it announces changes in senior management remuneration and contract terms. The document length (6953 characters) and detailed content support this classification with high confidence.
2023-08-30 English
Ceasing to be a substantial holder for MVP 3 pages 154.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests of a substantial shareholder, including dates, nature of changes, and securities affected. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory notice about shareholding changes.
2023-08-27 English
FY23 Full Year Results Announcement Details 1 page
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 15 August 2023, stating that Medical Developments International Ltd will announce its full year financial results for the fiscal year ending 30 June 2023 on 31 August 2023. It also mentions a broadcast for investors on the same day. The document does not contain any actual financial data or detailed results; it is merely an announcement of the upcoming results release and related investor event. The document length is short (1682 characters), and it fits the pattern of a report publication announcement rather than the report itself. Therefore, according to the MENU VS MEAL RULE, this document should be classified as a Report Publication Announcement (RPA).
2023-08-14 English
Application for quotation of securities - MVP 6 pages 27.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and whether the securities rank equally with existing ones. This is a regulatory announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. It is not a full financial report, earnings release, or management discussion. The document fits the category of Share Issue/Capital Change announcements.
2023-08-02 English
Response to ASX Price Query 3 pages 679.7KB
Regulatory Filings Classification · 95% confidence The document is a formal response letter from Medical Developments International Limited (MVP) to the ASX Compliance regarding a price query about recent trading activity in MVP's securities. The letter references ASX Listing Rules, continuous disclosure obligations, and compliance confirmations. It does not contain financial statements, earnings data, or detailed financial analysis. Instead, it is a regulatory communication addressing market compliance and disclosure matters. The document length is 6895 characters, which is relatively short and focused on regulatory compliance rather than financial reporting. Therefore, this document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-07-25 English
Notification of cessation of securities - MVP 4 pages 23.8KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of securities, specifically performance rights, for Medical Developments International Limited. It details the number of securities that have ceased, the reason for cessation (departing employee), and the updated issued capital following these changes. The document is an announcement of changes in the company's issued capital related to securities that have ceased, rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed analysis but is a regulatory announcement about securities status changes. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-12 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.